安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- What Is Triple-Negative Breast Cancer (TNBC)? - NCI
Triple-negative breast cancer (TNBC) makes up about 15% of all breast cancers It is usually diagnosed at a later stage, grows more quickly, and is more likely to come back than other types of invasive breast cancer
- Triple-negative Breast Cancer | Details, Diagnosis, and Signs
Triple-negative breast cancer (TNBC) is an aggressive type of invasive breast cancer TNBC differs from other types of invasive breast cancer in that it tends to grow and spread faster, has fewer treatment options, and tends to have a worse prognosis (outlook)
- Triple-negative breast cancer - Wikipedia
Triple-negative breast cancer comprises 15–20% of all breast cancer cases [3] and affects more women with a mutation in the BRCA1 gene than other breast cancers [4]
- Triple-negative breast cancer: 7 things you should know
Triple-negative breast cancer (TNBC) is a type of breast cancer that does not have the same receptors as most other types of breast cancer It’s an aggressive disease with a high rate of recurrence
- Triple Negative Breast Cancer Treatment Options and Limitations: Future . . .
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptors (HER2) The survival rate for TNBC is generally worse than other breast cancer
- Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a rare yet fast-growing and aggressive cancer that accounts for approximately 10-15% of all breast cancer cases TNBC is usually invasive ductal carcinoma (IDC) and has its own specific pathology findings
- Ecotypes of triple-negative breast cancer in response to . . . - Nature
Triple-negative breast cancer (TNBC) is an aggressive subtype that is frequently treated with chemotherapy, but only half of the patients respond well and have good clinical outcome1,2
- How Is Triple-Negative Breast Cancer Treated? - NCI
Triple-negative breast cancer (also called TNBC) does not have targets that are typically used to treat other types of breast cancer, but treatment options are available
|
|
|